Sign In
Buy MASI
$179.95
+0 (+0%)
At Close: Jun 23, 2026
What's in Store for DENTSPLY SIRONA (XRAY) in Q3 Earnings?
03:50pm, Tuesday, 08'th Nov 2022 Zacks Investment Research
DENTSPLY SIRONA's (XRAY) third-quarter results are likely to reflect strong performance in the Technologies & Equipment business.
Why Masimo (MASI) Might Surprise This Earnings Season
12:51pm, Monday, 07'th Nov 2022
Masimo (MASI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
2 Under-the-Radar Medtech Stocks to Buy Now
11:40am, Saturday, 05'th Nov 2022 The Motley Fool
Don't count out these discounted medical technology stocks.
2 Under-the-Radar Medtech Stocks to Buy Now
07:40am, Saturday, 05'th Nov 2022
Don't count out these discounted medical technology stocks.
ConforMIS (CFMS) Reports Q3 Loss, Misses Revenue Estimates
11:25pm, Wednesday, 02'nd Nov 2022 Zacks Investment Research
ConforMIS (CFMS) delivered earnings and revenue surprises of -14.29% and 0.79%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Can Cigna's (CI) Q3 Earnings Beat on Evernorth Performance?
03:59pm, Wednesday, 02'nd Nov 2022 Zacks Investment Research
The third-quarter results of Cigna (CI) are likely to reflect a rise in total medical customers.
Cardinal Health (CAH) to Post Q1 Earnings: What's in Store?
04:40pm, Monday, 31'st Oct 2022 Zacks Investment Research
Cardinal Health's (CAH) first-quarter fiscal 2023 results are likely to reflect solid performance in the Pharmaceutical segment. However, inflation and supply chain constraints are likely to have cont
Why Masimo (MASI) is Poised to Beat Earnings Estimates Again
04:10pm, Friday, 28'th Oct 2022 Zacks Investment Research
Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Masimo (MASI) is Poised to Beat Earnings Estimates Again
01:33pm, Friday, 28'th Oct 2022
Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Zacks Analyst Blog Highlights Nevro, Masimo, Abiomed and Glaukos
11:36am, Friday, 28'th Oct 2022 Zacks Investment Research
Nevro, Masimo, Abiomed and Glaukos are part of the Zacks top Analyst Blog.
4 MedTech Stocks Set to Outpace Q3 Earnings Estimates
12:51pm, Thursday, 27'th Oct 2022 Zacks Investment Research
Let us take a look at some MedTech stocks, NVRO, MASI, ABMD and GKOS, which are poised to beat on third-quarter earnings.
4 MedTech Stocks Set to Outpace Q3 Earnings Estimates
10:33am, Thursday, 27'th Oct 2022
Let us take a look at some MedTech stocks, NVRO, MASI, ABMD and GKOS, which are poised to beat on third-quarter earnings.
Apple Sues Medical Device Company Masimo, Says It Copied Apple Watch
10:28pm, Thursday, 20'th Oct 2022
Masimo sued Apple last year over the use of a blood oxygen censor.
Edwards Lifesciences (EW) to Report Q3 Results: Wall Street Expects Earnings Growth
02:01pm, Wednesday, 19'th Oct 2022 Zacks Investment Research
Edwards Lifesciences (EW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Masimo (MASI) Q3 Earnings Expected to Decline
02:01pm, Tuesday, 18'th Oct 2022 Zacks Investment Research
Masimo (MASI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
